E
Turnstone Biologics Corp. TSBX
$0.35 $0.0319.72% NASDAQ
Recommendation
Prev Close
$0.319
Volume
246,727
Avg Vol (90D)
173,184
Market Cap
$7.38M
Dividend & Yield
--
52-Week Range
$0.29 - $3.39
P/E (TTM)
--
EPS (TTM)
-$3.08
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Turnstone Biologics Reports 2024 Financial Results
4/2/2025 - TipRanks Financial Blog
Turnstone Biologics reports Q4 EPS (56c) vs (73c) last year
3/30/2025 - TipRanks Financial Blog
Turnstone Biologics reports Q4 EPS (56c) vs (73c) last year
3/30/2025 - The Fly
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
3/29/2025 - GuruFocus
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
3/29/2025 - GuruFocus
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
3/29/2025 - Globe Newswire
Turnstone Biologics (NASDAQ:TSBX) Stock Rating Lowered by Piper Sandler
2/8/2025 - Ticker Report
Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock?
2/7/2025 - Zacks Investment Research
Turnstone Biologics just downgraded at Piper Sandler, here's why
2/5/2025 - The Fly
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
2/4/2025 - GuruFocus
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
2/4/2025 - Globe Newswire
Head to Head Contrast: Turnstone Biologics (NASDAQ:TSBX) versus Inhibikase Therapeutics (NYSE:IKT)
2/1/2025 - Ticker Report
Reviewing Turnstone Biologics (NASDAQ:TSBX) & Quantum Genomics Soci t Anonyme (OTCMKTS:QNNTF)
1/20/2025 - Ticker Report
Turnstone Biologics Corp. (NASDAQ:TSBX) Shares Bought by Fmr LLC
12/18/2024 - Ticker Report
Point72 Asset Management L.P. Sells 186,362 Shares of Turnstone Biologics Corp. (NASDAQ:TSBX)
12/12/2024 - Ticker Report
BofA gets more bearish on Turnstone Biologics, downgrades shares
11/15/2024 - The Fly
Leerink Partners Keeps Their Hold Rating on Turnstone Biologics Corp. (TSBX)
11/14/2024 - TipRanks Financial Blog
Turnstone Biologics Faces Financial and Operational Challenges
11/13/2024 - TipRanks Financial Blog
Turnstone Biologics reports Q3 EPS (74c), consensus (86c)
11/12/2024 - TipRanks Financial Blog
Turnstone Biologics reports Q3 EPS (74c), consensus (86c)
11/12/2024 - The Fly
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
11/12/2024 - Globe Newswire
Turnstone Biologics presents two posters on methods for TIL selection at SITC
11/5/2024 - The Fly
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
11/5/2024 - Globe Newswire
Turnstone Biologics (NASDAQ:TSBX) Downgraded by Bank of America
10/17/2024 - Ticker Report
Turnstone Biologics downgraded to Neutral at BofA after restructuring
10/14/2024 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$71.53M
EBIT (TTM)
-$73.37M
Net Income (TTM)
-$70.84M
Balance Sheet
Total Assets (Q)
$40.14M
Total Debt (Q)
$1.19M
Total Liabilities (Q)
$8.67M
Book Value Per Share (Q)
$1.36
Cash Flow
Cash from Operations (TTM)
-$67.44M
Cash from Investing (TTM)
$78.56M
Cash from Financing (TTM)
$11.00K
Net Change in Cash (TTM)
$11.13M
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-2.78%
30-Day Total Return
-5.69%
60-Day Total Return
-27.84%
90-Day Total Return
-27.39%
Year to Date Total Return
-34.88%
1-Year Total Return
-87.93%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 24, 2025 - $0.29
52-week High
May 08, 2024 - $3.39
Valuation
Market Cap
$7.38M - Nano Cap
Enterprise Value
-$20.36M
Price/Sales (TTM)
--
Price/Book (Q)
0.23
Dividends and Shares
Shares Outstanding
23.06M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
turnstonebio.com
Phone Number
347 897 5988
Address
9310 Athena Circle
La Jolla, CA 92037
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company’s lead product includes TIDAL-01 that... more
NASDAQ 04/25/2025 3:58PM Eastern Quotes delayed